Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Isabelle, Daviaud"'
Autor:
Anne Mosnier, Saverio Caini, Isabelle Daviaud, Elodie Nauleau, Tan Tai Bui, Emmanuel Debost, Bernard Bedouret, Gérard Agius, Sylvie van der Werf, Bruno Lina, Jean Marie Cohen, GROG network
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0136186 (2015)
Studies that aimed at comparing the clinical presentation of influenza patients across virus types and subtypes/lineages found divergent results, but this was never investigated using data collected over several years in a countrywide, primary care p
Externí odkaz:
https://doaj.org/article/4e8632e3ca844762aafa1537a3f5c042
Autor:
Jean Marie Cohen, Maria Laura Silva, Saverio Caini, Meral Ciblak, Anne Mosnier, Isabelle Daviaud, Gonçalo Matias, Selim Badur, Martine Valette, Vincent Enouf, John Paget, Douglas M Fleming, IBGP study team
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139431 (2015)
Influenza B represents a high proportion of influenza cases in some seasons (even over 50%). The Influenza B study in General Practice (IBGP) is a multicenter study providing information about the clinical, demographic and socio-economic characterist
Externí odkaz:
https://doaj.org/article/642df94b9a6d462d9de9f633407d88d7
Autor:
Esther Kissling, Marta Valenciano, Jean Marie Cohen, Beatrix Oroszi, Anne-Sophie Barret, Caterina Rizzo, Pawel Stefanoff, Baltazar Nunes, Daniela Pitigoi, Amparo Larrauri, Isabelle Daviaud, Judit Krisztina Horvath, Joan O'Donnell, Thomas Seyler, Iwona Anna Paradowska-Stankiewicz, Pedro Pechirra, Alina Elena Ivanciuc, Silvia Jiménez-Jorge, Camelia Savulescu, Bruno Christian Ciancio, Alain Moren
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27622 (2011)
BackgroundIn the third season of I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe), we undertook a multicentre case-control study based on sentinel practitioner surveillance networks in eight European Union (EU) member states to estimate
Externí odkaz:
https://doaj.org/article/1d0190278a464d8aa1e65e79e1b87072
Autor:
Bruno Lina, Anne Mosnier, Sylvie van der Werf, Saverio Caini, Isabelle Daviaud, Jean Cohen, Jean-Michel Mansuy, Hervé Berche
Publikováno v:
Vaccine
Vaccine, Elsevier, 2017, 35 (16), pp.2076-2083. ⟨10.1016/j.vaccine.2017.02.067⟩
Vaccine, 2017, 35 (16), pp.2076-2083. ⟨10.1016/j.vaccine.2017.02.067⟩
Vaccine, Elsevier, 2017, 35 (16), pp.2076-2083. ⟨10.1016/j.vaccine.2017.02.067⟩
Vaccine, 2017, 35 (16), pp.2076-2083. ⟨10.1016/j.vaccine.2017.02.067⟩
International audience; Vaccine-induced protection against influenza is not optimal, however it has been suggested that the vaccine may reduce the severity of symptoms among those who develop illness despite being vaccinated. We tested this hypothesi
Autor:
Bruno Lina, Mehdi Benchaib, Jean-Sébastien Casalegno, Isabelle Daviaud, Anne Mosnier, Astrid Vabret, Sylvie van der Werf, Martine Valette, Daniel Eibach, Jean Claude Soulary, Jean Cohen, Vincent Enouf, Sylvie Behillil
Publikováno v:
Eurosurveillance
Eurosurveillance, European Centre for Disease Prevention and Control, 2017, 22 (14), ⟨10.2807/1560-7917.ES.2017.22.14.30504⟩
Eurosurveillance, 2017, 22 (14), ⟨10.2807/1560-7917.ES.2017.22.14.30504⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2017, 22 (14), ⟨10.2807/1560-7917.ES.2017.22.14.30504⟩
Eurosurveillance, 2017, 22 (14), ⟨10.2807/1560-7917.ES.2017.22.14.30504⟩
International case definitions recommended by the Centers for Disease Control and Prevention (CDC), the European Centre for Disease Prevention and Control (ECDC), and the World Health Organization (WHO) are commonly used for influenza surveillance. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45498922b5adef00d135e404e64f10f7
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01753121/document
https://hal-univ-lyon1.archives-ouvertes.fr/hal-01753121/document
Autor:
Ouzan, Denis, Anne, Mosnier, Penaranda, Guillaume, Isabelle, Daviaud, Barat, Françoise, Helene, Joly, Muntlak, Monelle, Marie, Cohen Jean
Publikováno v:
In Journal of Hepatology August 2020 73 Supplement 1:S512-S513
Autor:
Judit Krisztina Horváth, Emilia Lupulescu, Joan O Donnell, Monika Roberta Korczyńska, Alain Moren, Antonino Bella, Jean Cohen, Esther Kissling, Annicka Reuss, Caterina Rizzo, Isabelle Daviaud, Lisa Domegan, Amparo Larrauri, Iwona Paradowska-Stankiewicz, Chris Robertson, Baltazar Nunes, Marta Valenciano, Udo Buchholz, Daniela Pitigoi, Ausenda Machado, Beatrix Oroszi, Alin Gherasim
Publikováno v:
Eurosurveillance
Eurosurveillance, European Centre for Disease Prevention and Control, 2016, 21 (16), ⟨10.2807/1560-7917.ES.2016.21.16.30201⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2016, 21 (16), ⟨10.2807/1560-7917.ES.2016.21.16.30201⟩
Influenza vaccines are currently the best method available to prevent seasonal influenza infection. In most European countries one dose (or two doses for children) of seasonal vaccine is given from September to December to the elderly and other targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ed9cdc0701a56f225624166f33f36e
https://hal.archives-ouvertes.fr/hal-01597277
https://hal.archives-ouvertes.fr/hal-01597277
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 66:S383
Context Much attention has been paid to influenza over the past three decades with a rare focus on influenza B. Since 2000, two distinct influenza B lineages (Yamagata and Victoria) circulate alternately or simultaneously, raising the issue of potent
Autor:
Clément Turbelin, Cédric Laouénan, Thomas Hanslik, Bruno Lambert, Catherine Leport, Thierry Blanchon, Anne Mosnier, Félicité Geffrier, Isabelle Daviaud, Xavier Duval
Publikováno v:
Antiviral Therapy
Antiviral Therapy, International Medical Press, 2015, 20 (7), pp.753-61. ⟨10.3851/IMP2945⟩
Antiviral Therapy, 2015, 20 (7), pp.753-61. ⟨10.3851/IMP2945⟩
Antiviral Therapy, International Medical Press, 2015, 20 (7), pp.753-61. ⟨10.3851/IMP2945⟩
Antiviral Therapy, 2015, 20 (7), pp.753-61. ⟨10.3851/IMP2945⟩
Background In a context of controversy about influenza antiviral treatments, this study assessed primary healthcare physicians’ prescription of neuraminidase inhibitors (NIs) in France during pandemic and seasonal influenza between 2009 and 2013. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afcc313680b012605d605dc2206168ab
https://www.hal.inserm.fr/inserm-01242944/file/HAL-Inserm_retroDINA_Antivir-Ther_2015.pdf
https://www.hal.inserm.fr/inserm-01242944/file/HAL-Inserm_retroDINA_Antivir-Ther_2015.pdf
Autor:
Maria-Laura Silva, John Paget, Saverio Caini, Anne Mosnier, Isabelle Daviaud, Gonçalo Matias, Douglas M. Fleming, Selim Badur, M. Valette, Meral Akcay Ciblak, Vincent Enouf, Ibgp study team, Jean Cohen
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139431 (2015)
PLoS ONE
PLoS One, 10
PLoS One, 10, 10
PLoS ONE
PLoS One, 10
PLoS One, 10, 10
Contains fulltext : 152751.PDF (Publisher’s version ) (Open Access) Influenza B represents a high proportion of influenza cases in some seasons (even over 50%). The Influenza B study in General Practice (IBGP) is a multicenter study providing infor